The Changing Landscape for New Drug Development: Medical Countermeasures (MCMs) as a Case Study
Crossref DOI link: https://doi.org/10.1007/978-3-030-16061-6_7
Published Online: 2019-08-14
Published Print: 2019
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Milne, Christopher-Paul
Funding for this research was provided by:
Merck KGaA
Text and Data Mining valid from 2019-01-01
Chapter History
First Online: 14 August 2019
Free to read: This content has been made available to all.